Environment Ministers must reconsider wastewater EPR rules as serious scientific and legal concerns mount

New public procurement rules must safeguard patient access and encourage investment in manufacturing and supply resilience

Parliament’s Legal Affairs Committee calls for a stronger SPC Manufacturing Waiver to boost biomanufacturing in Europe

ECJ Advocate General’s opinion proposes to annul the EPR cost allocation under the EU wastewater rules

UWWTD: European Parliament stands with patients and security of medicine supplies

The off patent medicines industry is a strategic partner for Europe

Twenty years of the Legal Affairs Conference: Driving Europe’s competitiveness and timely access to medicines

Medicines for Ireland and Medicines for Europe welcome Irish Court referral of EU Water Directive to CJEU

Critical Medicines Act: a step forward for secure medicines supply

The Biosimilar Advantage: Powering patient access and industrial resilience